The R&D center has been conducting research and development focusing on medical devices such as hyaluronic acid fillers
and focusing on the development of next-generation biopolymer dermal fillers and after-care cosmetics
based on efficient cross-linking and complete residual cross-linking agent removal technology.
We have commercialized 10 different types and are selling them domestically and internationally. In addition, we are conducting preclinical and clinical trials through the development of new high-content, high-functional products.
We are conducting research on next-generation dermal fillers with new formulations and site-specific functionality using biocompatible polymers other than hyaluronic acid.
We are developing various functional skin care products that can be used before and after filler treatment, such as skin soothing, wound treatment, skin regeneration, wrinkle improvement, whitening, and blemish improvement.